The fact that potentially you could dose this at home if you wanted to, it suddenly makes this a much easier medication to give out,” says the study's lead author Paul Glue, a psychiatrist at the University of Otago in Dunedin, New Zealand.
Previous analyses have suggested that slow-release formulations of ketamine tend to have fewer side effects. Glue and his colleagues therefore proposed that an extended-release tablet could be a well-tolerated and convenient option for people with severe or treatment-resistant depression.
Collection
[
|
...
]